Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01578083 · ClinicalTrials.gov registry record
Chemotherapy-Induced Cognitive Impairment
A clinical trial, sponsored by Jay F. Piccirillo, MD.
- Completed
- Registry status
- 28
- Enrollment target
NCT01578083 is a clinical trial that has completed, run by Jay F. Piccirillo, MD. The registered enrollment target is 28 participants.
The verdict
NCT01578083 has completed, sponsored by Jay F. Piccirillo, MD.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The investigators overall research hypothesis is that systemic chemotherapy induces structural changes in the white matter of the brain as demonstrated with Diffusion Tensor Imaging (DTI) and functional changes in well-defined cortical neural networks as demonstrated by resting-state functional connectivity MRI (rs-fcMRI). The investigators believe these structural and functional changes are responsible for the cognitive symptoms associated with chemotherapy-induced cognitive impairment (CICI). The Specific Aim for this study is: To assess the impact of chemotherapy on structural white matter as defined by DTI and functional cognitive networks as defined by rs-fcMRI by comparing a sample of breast cancer survivors with self-reported CICI to breast cancer survivors without CICI. Hypothesis: Post-chemotherapy breast cancer patients with self-reported CICI will have abnormal structural connections characterized by DTI-defined disruptions in fractional anisotropy (FA) and mean diffusivity (MD) and abnormal functional connectivity characterized by rs-fcMRI-defined disruptions in cognitive networks when compared to patients without self-reported CICI.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2012-04 |
| Est. Completion | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01578083
The ClinicalTrials.gov registry entry for NCT01578083 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jay F. Piccirillo, MD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01578083 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01578083 about?
NCT01578083 is a clinical study titled "Chemotherapy-Induced Cognitive Impairment". The investigators overall research hypothesis is that systemic chemotherapy induces structural changes in the white matter of the brain as demonstrated with Diffusion Tensor Imaging (DTI) and functional changes in well-defined cortical neural networks as demonstrated by resting-state functional conn...
What is the current status of trial NCT01578083?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2012-04. Estimated completion is 2012-12.
Who is sponsoring clinical trial NCT01578083?
This trial is sponsored by Jay F. Piccirillo, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.